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INTRODUCTION 
The  problem of  penicillin  allergy  is  of  considerable  importance  in  both  clinical 
medicine and theoretical  immunology.  Up to now investigation  in penicillin 
allergy  has been hampered by a lack of knowledge of the chemical reactions 
which occur between penicillin  and tissue  proteins  to  form the "penicillin  anti- 
gen," as  well  as  by lack of  knowledge as  to  the  identity  of the specific  allergic 
determinant groups of  this  antigen. 
It  is  generally  believed  that  low  molecular weight  allergens  induce the  allergic 
state  and elicit  allergic  reactions  by first  combining through a covalent bond 
with tissue  proteins  to form the complete antigen.  This view is  based on the 
classic  studies  of  Landsteiner,  Jacobs,  Chase, Gell,  and  Eisen  (1-6),  who showed 
that  only  those  compounds which could  react  irreversibly  with  proteins  or  with 
protein  model compounds could sensitize  or  elicit  an allergic  reaction. 
The great  majority of  clinical  sensitizers,  however, such as  penicillin,  the  sul- 
fonamides, and aspirin  have not  been  shown to  react  irreversibly  with  proteins. 
In these  cases it is plausible  to consider  that either  a  trace  contaminant,  or a 
degradation or metabolic product may be the actual proantigen 1 responsible for 
allergy to the parent compound. With regard to this consideration, Landsteiner 
and Di Somma reported that guinea pigs with allergic contact dermatitis to pic- 
ric acid gave allergic cross-reactions to its reduction product, picramic acid (7). 
Also, Mayer has shown that human beings and guinea pigs with allergic contact 
* Dazian Foundation Research Fellow,  1958-1959. 
Present address:  Department of Pathology, New  York University, School of Medicine, 
New York, New York. 
1 By "proantigen" is meant a low molecular weight chemical allergen that reacts irreversi- 
bly with tissue protein to form the complete antigen.  This term was introduced  by Cell et al. 
(3). 
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dermatitis  to  p-pheuylenediamine  cross-reacted  to  its  oxidation  products  p- 
benzoquinone  and p-quinonediimine  (8). 
Penicillin G (PG) 2 has not been demonstrated to undergo irreversible reaction 
with proteins or with low molecular weight amines, thiols, or disulfides in neu- 
tral aqueous solution (9,  10). In view of the reversible binding of salts of PG to 
serum albumin (11), it might be considered that PG acts as an allergen by virtue 
of its reversible binding to tissue proteins. There is no clear evidence in favor of 
this  possibility,  and  some data  have  been obtained  which  indicate  that  such 
easily dissociable complexes are incapable of inducing the allergic state (6). 
In the present work, the patterns of allergic cross-reactivity among PG and 
its degradation  products  were studied  using  allergic contact dermatitis  in the 
guinea pig as the test system. Three degradation products of PG, D-benzylpeni- 
cillenic acid (BPE) D-penicillamine (PSH), and D-benzylpenicilloic acid  (BPO) 
were found to cross-react with PG. By correlating these immunologic data with 
data on the in vitro degradation pathways of PG and on the chemical reactivi- 
ties of its degradation products in aqueous solution at pH 7.5 (12-15), a schema 
has emerged which describes the chemical reactions which may be involved in the 
in vivo formation of the penicillin antigen. This schema is presented in the Dis- 
cussion. 
Degradation  Pathways of PG.--The only data available on the in vivo degradation 
of PG are those of Walshe (16) who isolated a  compound with some of the properties 
of PSH  ~ from the urine of patients given large doses of PG. In vitro,  PG is degraded 
as follows (Text-fig. 1):- 
In pH 7.5 phosphate buffer solution in vitro, PG (Ia) is degraded to yield mainly 
a mixture of diastereomers of BPO (II) (12). This reaction exhibits first order kinetics 
and proceeds at a rate of 1.2 per cent per hour at 37 ° (17). The appearance of a small 
quantity of BPE (III) was detected in this degrading PG solution (12). 
In aqueous solution,  BPO is further degraded by mercuric chloride  to PSH  (V), 
benzylpenilloaldehyde (VIII), and CO, (18 a). This degradation proceeds presumably 
through  the intermediate D-benzylpenamaldic acid  (VI), which  is a  Schiff base and 
readily decomposes to PSH and benzylpenaldic acid  (VII) (18 b, 19 a).  Free benzyl- 
penaldic acid is unstable, and is immediately decarboxylated  to benzylpenilloaldehyde 
(18 c). BPE is degraded to 2-benzyl-4-sodium hydroxymethylene-(5)-oxazolone (BSO) 
(IV) and PSH by aqueous sodium hydroxide (19 b). 
At alkaline pH, PG is hydrolyzed to the a-diastereomer of BPO (18 d, 19 c) and at 
2 The following abbreviations are used: 
PG  =  (penicillin G); BPE =  (D-benzylpenicillenic acid); 
BPO  =  (D-benzylpenicilloic acid) ; PSH  =  (D-penicillamine)  ; 
BSO  =  (2-benzyl-4-sodium  hydroxymethylene-(5)-oxazalone); 
PSSCy =  (D-penicillamine-cysteine mixed  disulfide). 
3 This compound  may be penicillamine  disulfide. The identifying  tests performed on this 
compound,  paper chromatography,  bromine oxidation,  and  elemental  analysis  would  not 
distinguish PSH from penicillamine disulfide. B.  B.  LEVINE  1133 
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acid pH, PG rearranges to D-benzylpenillic  acid (IX)  (19 d). D-Benzylpenillic acid is 
further  degraded  to  D-benzylpenillamine  (X)  by  aqueous  mercuric  chloride  (19  e). 
Detailed  discussions of  the chemistry of penicillin and  its degradation products  are 
contained in references 12 to 20. 
EXPERIMENTAL AND RESULTS 
Materials.--Crystalline  sodium penicillin G  (NaPG)  (1650 units per mg.) was generously 
furnished by Pfizer Laboratories, Brooklyn,  New  York.  Crystalline potassium penicillin G 
(KPG)  (lot E-7941)  was obtained from Bristol Laboratories,  Syracuse,  New  York.  It bio- 
assayed at 1600 units per rag. and was 99 per cent pure; the remainder was penicillins K  and 
F  (manufacturer's assay).  Crystalline sodium penicillin O  (cer-o-cillin, sodium, lot KM-008) 
was furnished by the Upjohn Co., Kalamazoo, Michigan. It contained 0.06 to 0.10 per cent 
PG as an impurity (manufacturer's assay).  D-Penicillamine.HCl.~  H20,  (a)~  =  --49.7 ° 
(1 per cent in 1 N NaOH),  and z-penicillamine.HCl.~ H20,  (a)g  =  -[-[-60.2  °  (1  per  cent 
anhydrous free amine in 1 N NaOH),  were purchased from California Corporation for Bio- 
chemical Research,  Los  Angeles,  California.  These crystalline materials were  prepared  by 
synthesis and were  over  99 per  cent pure  (manufacturer's assay).  Both compounds  gave 
strongly positive nitroprusside reactions.  D-Cysteine.HC1,  (a)"  =  --3.4  °  (2  per  cent  in 
water), was purchased from  California Corporation.  It exhibited a  strongly positive nitro- 
prusside reaction. 
N-Acetyl-D-penicillamine was prepared from PSH by reaction with acetic anhydride (19 
f),  and was crystallized twice from water. M.p.  =  192-193 ° (micro., dec.). 4 Its nitroprusside 
reaction was strongly positive, and it ran as one spot (Rf =  0.79)  on phenol-water descending 
paper chromatography. ~Penicillamine disulfide was prepared by air oxidation of PSH (19 g), 
and was crystallized from water-ethanol and finally from water-acetone.  M.p.  =  204-205 ° 
(cap., dec.). Its nitroprusside reaction was negative, and it ran as one spot  (Ry  =  0.65)  on 
phenol-water  descending  paper  chromatography.  Monosodium  D-a-benzylpenicilloate was 
prepared by alkaline hydrolysis of NaPG  (19 c) and was crystallized from water and finally 
from water-acetone. M.p.  --  154-155 ° (micro., dec.); (or) ~,  =  -[-[-125  ° (0.772  per cent in 0.2 
pH 7.5 phosphate buffer). D-Benzylpenillic acid was prepared by rearrangement of NaPG 
in acid aqueous solution (19 d) and recrystallized twice from water. M.p.  =  185-186  ° (cap., 
dec.); Xmx 275 m# (shoulder), e =  6500. 
n-Benzylpenillamine.HC1 was  prepared  by mercuric  chloride  degradation of  D-benzyl- 
penillic acid followed by H2S decomposition of the resulting mercuric mercaptide of D-benzyl- 
penillamine (19 e). It was crystallized twice from acetone-ether. M.p.  =  172-173 ° (cap., dec.). 
Its  nitroprusside  reaction  was  strongly  positive.  Benzylpenilloaldehyde was  prepared  by 
synthesis (19 h), and crystallized from acetone and finally from benzene. M.p.  =  112-113 ° 
(cap.).  Its  2,4-dinitrophenylhydrazone derivative prepared  by  the method  of  Shriner and 
Fuson (21) showed the expected melting point of 194-195°C.  (micro., dec.)  (19 i). 
BPE was prepared by rearrangement of PG with mercuric chloride followed by H~S de- 
composition of  the resulting mercuric mercaptide of  BPE.  Its preparation  is  described  in 
detail in another report (13). Its nitroprusside reaction was strongly positive. It exhibited the 
expected ultraviolet absorption maximum at ~  322 m/~ with ~ =  25,600,  which corresponds 
to 96 per cent purity  5 (see below under BPE content of test compounds). BSO  2 was prepared 
4 Melting points were determined with a capillary melting point apparatus (cap.), or with 
a  Fisher-Johns microblock apparatus (micro.) and are uncorrected. 
5 Approximately 11 per cent of the BPE content of the preparation is present in the oxi- 
dized (disulfide) form. BPE disulfide appears to be unreactive in neutral aqueous solution (13). B. B. LEVINE  1135 
by alkaline degradation of BPE  (19 b), and was crystallized from water and finally from an 
ethyl acetate-methanol mixture. M.p.  =  236-237  ° (micro., dec.). In 0.01  x~ NaOH solution, 
it exhibited the expected ultraviolet absorption peaks at Xmz 299 m/z, e  --  18,300,  and Xmz 
240 m#, •  --  5,400  (19 j). 
Tween 80,  tris  (polyoxyethylene) sorbitan monooleate was kindly donated by the Atlas 
Powder Corporation, New York. Other chemicals were of reagent grade. 
TABLE  I 
Purity of Test Compounds* 
Test compound 
1.  Potassium penicillin G 
2.  Sodium penicillin O 
3.  D-Penicillamine-  HCL. ~  H20 
4.  Monosodium D-ot-benzylpenicilloate 
5.  D-Benzylpenillic acid 
6.  D-B  ertzylpenillamine  •  HCL 
7.  D-Benzylpenicillenic acid 
8.  BenzylpeniUoaldehyde 
9.  2-Benzyl-4-sodium hydroxymethylene- 
(5) -oxazolone 
Penicillin G 
content 
Per cent by 
weight 
99§ 
0.06-0.1011 
0 
0 
0 
0 
0.02 
0 
0 
D-Penicl]lamine 
content 
Molar per cents 
0 
0 
99+ 
0 
0 
0 
0.1 maximum 
0 
0 
v-Benzylpeni- 
cillenie acid 
content 
Molar per cents 
0 
0.1 per cent¶ 
0 
0 
0 
0 
96** 
0 
0 
* See text for analytical methods  and limits of sensitivity. 
J; Mols D-penicillamine or D-benzylpenicillenic acid per 100 mols test compound. 
§ The other 1 per cent is composed of penicillins K  and G  (manufacturer's assay). 
[[ Manufacturer's assay. 
¶ Probably present  as  allylmercaptomethylpenicillenic acid. 
** Approximately 11 per cent of the BPE present in the preparation is in the disulfide 
form (13). 
Purity of Test Compounds.--With the exception of BPE, the test compounds 
were all crystalline and exhibited sharp melting points. BPE, PSH, and PG im- 
purities in the test compounds were assayed quantitatively as these three com- 
pounds were found to exhibit strong allergic activity in the PG contact derma- 
titis system. The analytical procedures are described below, and the results are 
shown in Table I. The test compounds contained no detectable PG, BPE, or 
PSH impurity except for sodium penicillin O which contained 0.06 to 0.10 per 
cent PG and 0.1 per cent "penicillenic acid, ''e and BPE which contained 0.02 
per cent PG and a maximum PSH content of 0.1 per cent (see below under PSH 
content of test compounds). 
Penicillin  Content of Test  Compounds.--The  quantity of  penicillin impurity in  the  test 
compounds was determined by bioassay of 1 rag. per ml. solutions of these materials in 0.01 
6 This is probably D-allylmercaptomethylpenicillenic acid. 1136  FORMATION  OF PENICILLIN ANTIGEN 
~J pH 6 phosphate buffer/A cylinder plate method with Sarcina lutea as the test organism 
was employed (22).  This method can detect less than 0.01  unit per ml. of penicillin activity, 
or less than 0.01  per cent by weight of PG impurity. The test substances did not interfere 
with the analysis, as added PG was detectable. 
BPE Content of Test Compounds.--The  amount of BPE impurity of the test compounds 
was assayed by measuring the optical density (O.D.)  at X~x 322 m/z of freshly prepared 1.00 
X  10  -2 M solutions of the test compounds in 0.1 ~ pH 7 phosphate buffer. Crystalline, synthetic 
D,L-benzylpenicillenic acid exhibits an ultraviolet absorption peak in 95 per cent ethanol at 
322 m# with e =  26,600 (23). This value is taken as the molar extinction coefficient of BPE. 
BPE exhibits the same molar extinction coefficient in pH  7 buffer solution as it does in 95 
per cent ethanol solution (13). Accordingly, a test compound containing more than 0.01 molar 
per cent of BPE impurity (tools BPE per 100 mols test compound), would exhibit an O.D. 
at ~m~x 322 m/z of more than 0.027.  In a  typical analysis, a  freshly prepared 1.00  X  10  -~  M 
solution of KPG exhibited an O.D. at ~ 322 m/z of 0.025 and no absorption peak was observed. 
KPG therefore contains less than 0.01  molar per cent of BPE impurity. O.D.  measurements 
were  made with the Beckman model  DU  spectrophotometer using  1 cm.  matched  quartz 
cuvettes. 
PSH Content of Test Compounds.--This  was determined by descending N-butanol-water- 
acetic acid paper chromatography on Whatman number 3 paper of 0.0256 millimol quantities 
of the test compounds. In a typical analysis, 9.5 mg. of KPG (0.0256 millimol) was chromato- 
graphed simultaneously with a mixture of 9.5 mg. KPG and 5.0 micrograms of PSH-HC1.1/~ 
H20 (0.0256  micromol). In order to gain maximum separation of the compounds, chromatog- 
raphy was allowed to continue until the solvent front was almost at the  end  of  the paper, 
about 45 cm. Mter color development with ninhydrin, the KPG-PSH mixture showed a  dis- 
tinct spot at R I  =  0.13  (PSH), well separated from the penicillin streak starting at R! =  0.21. 
KPG alone showed no PSH spot. Thus, there is less than 0.1 molar per cent PSH impurity 
in KPG.  In the case of monosodium D-a-benzylpenicilloate, the PSH  spot was not so well 
separated from  the penicilloate streak,  but the absence of  PSH  could still be determined. 
On paper chromatography, BPE exhibited a spot with the same R/as PSH which overlapped 
the BPE streak and corresponded in color intensity to 0.1 per cent PSH.  It is possible that 
this spot is an artifact, since BPE is prepared by a  method which should eliminate virtually 
all PSH  from it  (13). 
In order to determine whether the 0.02 per cent PG impurity and the 0.1 per 
cent  PSH  impurity  present  in  the  BPE  preparation  are  responsible  for  the 
strong  allergic cross-reactions  which occur among  BPE,  PSH,  and  PG  (Table 
V), PSH-sensitized  guinea pigs were tested with 0.1  ~  and  1.0  X  10  -4 ~  solu- 
tions of PSH,  and PG-sensifized animals were tested with 0.1 5,  1.0 X  10-  4 M, 
and 2.0 X  10  -5 M solutions of KPG.  PSH-sensitized guinea pigs which exhibited 
2q-  and 3-b reactions to 0.1 ~  PSH  gave only occasional 4- reactions to 10  -4 M 
PSH. PG--sensifized animals which reacted 2~  and 3-k  to 0.1 ~  KPG  exhibited 
negative reactions to 2  X  10-  5 ~  KPG  and gave occasional q- reactions to 10  -4 
KPG.  Thus,  the trace PSH  and PG  impurities present in the BPE  prepara- 
tion cannot  account  for  the  strong  cross-reactions  observed  to  occur  among 
BPE,  PG, and PSH  (Table V). Similarly, the trace PG impurity in the sodium 
71 wish to thank Dr.  H. Baker and Mr. O.  Frank of the Department of Chemistry, the 
Mount Sinai Hospital, New York, for their help in performing the bioassays. B. B. LEVINE  1137 
penicillin O  preparation  cannot  account  for the  strong  allergic cross-reactions 
which  occur  between  penicillins  O  and  G  (Table  IX).  Since  BPE-sensitized 
guinea pigs  which reacted 2+  and 3+  to 0.1 ~  BPE  exhibited only occasional 
4- reactions to 10-4~ BPE,  the 0.1 per cent "penicillenic acid" impurity present 
in sodium penicillin O  cannot account for the cross-reactions between penlcillins 
O  and  G  (Table IX). 
Sensitization of Guinea Pigs to PG and Its Degradation Produas.8---Male albino guinea pigs 
weighing 300 to 600 gin. were used for these experiments. They were maintained on Rockland 
guinea pig pellets and water at/libitum, and given fresh lettuce once a day. Sixty guinea pigs 
were sensitized with laG by six percutaneous applications of a  0.1  ~  solution of KlaG in a 
solvent composed of 95 per cent ethanol, methylcellosolve,  9 and  tween 80 (45:45:10 by vol- 
ume)  (ECT).  A  freshly prepared  solution was used for each application.  Each application 
consisted of 0.05 ml. spread with a fire-polished glass rod into a 2 cm. circular area on the dorsal 
skin surface clipped free of hair. The same skin area was used for each application since the 
impression was gained that a greater incidence of sensitization was obtained by this method 
than  by using different skin sites for each application. The patterns  of cross-reaction were 
the same for animals sensitized by each of these two methods. The applications were made 
on alternate days 3 times a week for 2 weeks.  After a  14 day rest period, the animals were 
patch-tested for hypersensitivity with 0.1 M KlaG in ECT solvent. Sensitization of groups of 
ten to forty guinea pigs with laSH, BlaE, benzylpenilloaldehyde, BSO, and BPO was accom- 
plished by the same procedure using 0.1 ~¢ solutions of the sensitizer.  These sensitizers were 
all dissolved in ECT solvent except for BlaO which was dissolved in a mixture of 1-120, methyl- 
cellosolve, and tween 80 (45:45:10 by volume) (WCT). After a 14 day rest period, the animals 
were tested for hypersensitivity with a 0.1 M solution of the sensitizer. 
In Table II is indicated  the percentage  of guinea pigs which became hyper- 
sensitive  to  PG  and  its  degradation  products.  Guinea  pigs  reacting  1+  and 
greater to 0.1 ~t solution of the sensitizer in ECT  or WCT  were considered sen- 
sitized.  PSH,  BPE,  and  benzylpenilloaldehyde  sensitized  85  to  90 per cent of 
the animals,  whereas PG,  BPO, and  BSO sensitized  50 per cent. 
Elicitation  of Allergic Reaaions.--The hair of the dorsal skin surface was closely clipped 
with an electric small animal clipper and a number 0000 blade. 1° Care was taken to mi~irni~ 
skin trauma during clipping. Twenty-four hours after clipping, 0.04 ml. of the test solution 
was gently spread into a circular area of 1.5 cm. diameter with a thin, fire-polished  glass rod. 
In many cases, multiple simultaneous skin testing was done, up to eight tests at a single time. 
This could be done since the skin area employed, a rectangular area of the dorsal skin surface 
from below the nuchal fat pad  to the middle of the sacrum and  5 cm. from the midline on 
either side, showed no consistent differences  in skin reactivity. However, it was found that 
multiple simultaneous skin testing slightly diminishes the intensity of the individual reaction. 
8 Some of the early experiments on the sensitization of guinea pigs to lag and laSH were 
done at  the Institute of Industrial  Medicine, New York University Postgraduate  Medical 
School, in collaboration with Dr. Herman N. Eisen presently of the Washington University 
School of Medicine, St. Louis, Missouri. I  wish to thank  Dr. Eisen for suggesting the use of 
tween 80. 
9 Ethylene glycol monomethyl ether. 
10 Purchased  from Oster Products, Inc., New York. 1138  FORMATION OF PENICILLIN ANTIGEN 
The tests were read 48 hours later, 4 hours after depilation with nair, a commercial depilatory. 
Reactions at 48 hours were recorded exclusively since it was found that both strong and weak 
allergic  reactions were at their maximum intensities at that time. The readings were graded 
as follows:- 
0, no visible reaction or faint erythematous stippling. 
4-, small areas of erythema in the test circle. 
1+, a homogeneous, sharply demarcated, slightly raised, mildly erythematous area. 
2+, a homogeneous, raised, moderately erythematous area. 
3-{-, a homogeneous, raised, intensely erythematous area. 
The solvent mixtures, ECT and WCT, were slightly irritant, giving usually negative re- 
actions and occasional 4- reactions (in approximately 15 per cent of the animals). This primary 
irritation was due to tween 80 since ethanol and methyl cellosolve gave consistently negative 
TABLE  II 
Results of Contact Sensitization of Guinea Pigs with Penicillin G and Its Degradation 
Products 
Sensitizer* 
Potassium penicillin G 
D-Peuicillamine •  HC1 
D-Benzylpenicilleuic  acid 
Monosodium-D-a-benzylpeuicilloate 
2-Benzyl-4-sodium hydroxymethylene- 
(5) -oxazolone 
BenzylpeniUoaldehyde 
3+ 
No. of animals reacting 
1+  0 and ± 
10  30 
7  5 
5  3 
4  5 
4  5 
1  1 
Percentage 
Sensitized$ 
50 
88 
85 
50 
50 
90 
* Guinea pigs were sensitized by six percutaneous applications of 0.1  ~  solution of the 
sensitizer in a tween 80 solvent (see text). 
The animals were patch-tested for delayed contact hypersensitivity with a  0.1  ~x solu- 
tion of the sensitizer in a  tween 80  solvent.  (See  text.)  Animals reacting 1+  or stronger 
were considered sensitized. 
reactions. Under these experimental conditions, tween 80 was not a sensitizer. The materials 
tested, except for BPE, were not primary irritants at the concentrations used, giving reactions 
indistinguishable from the solvent reaction in non-sensitized animals. BPE at 0.1  ~s concen- 
tration was slightly more irritant than ECT solvent alone; five of ten animals gave -4- reac- 
tions to 0.1 x, BPE in ECT as compared to negative reactions for  ECT  alone.  At  concen- 
trations of 0.01 ~  or less, BPE was non-irritant. Groups of four to six non-sensitized  animals 
were used to test for primary irritation. 
Only animals that had become sensitized were tested for cross-reactions. The solvent con- 
trois, tested simultaneously, were negative. Guinea pigs which reacted ±  to the solvent were 
eliminated from tabuiation. This introduced no bias, as these animals cross-reacted with the 
same patterns as did the others. It is to be noted that the slight solvent reactions might mask 
a  faint ailergic  response,  and conversely an  occasional faint  inflammatory  response to a 
given test material may be due to a  solvent reaction. 
The Effect of Tween 80 Solvents on Sensitization and Elicitation.--The  use of 
tween 80 mixtures as solvents for the test compounds was essential to effect both B. B. LEVINE  1139 
sensitization and elicitation of the delayed contact allergic reactions. Tween 80, 
a non-ionic detergent, acts presumably by increasing  intraepidermal  penetra- 
tion of these water-soluble allergens (4, 24). In PG-sensitized animals as well as 
in animals sensitized to both PSI-I and benzylpenilloaldehyde (Table III), test- 
ing with the sensitizer  in ECT solution yielded much stronger allergic reactions 
than did testing with the sensitizer  dissolved in a solvent mixture of 95 per cent 
TABLE  III 
The Effect of Tween 80 Solvent on the Intensity of the Delayed Contact Allergic 
Reaction* 
Sensitized to benzylpenilloaldehyde  (Paid) 
Elicitor~  Guinea pig No. 
1  2  3  4 
0.1 1  Pald in ECT solvent ........................  3+  2+  1+  1+ 
0.1 1  Pald in EC Solvent .........................  -4-  [  0  [  0  I  0 
ECT solvent ....................................  0  4-  [  0  [  0 
EC solvent .....................................  0  0  0  0 
Elieitor~ 
0.1 ~  PSH in ECT solvent ...................... 
0.1 ~  PSH in EC solvent ........................ 
ECT solvent ................................... 
EC solvent .................................... 
Sensitized to D-penicillamine (PSH) 
Guinea pig No. 
_2,  4 
3+j  3+  I  1+  r 
o  i  0  t  o  I 
o  L  +  i  0  I 
0  t0  io  i 
2+ 
0 
0 
0 
* See text for methods of sensitization  and elicitation. 
~t ECT solvent  ffi  95 per cent ethanol; methylcellosolve; tween 80 (45:45:10 by volume). 
EC solvent  =  95 per cent ethanol: methylcellosolve (1:1 by volume). The four elicitations 
were done  simultaneously.  PSH  and  Paid  at 0.1 ~  concentration in ECT solution were not 
primary irritants. 
ethanol and methylcellosolve (1:1 by volume) (EC). This same effect of tween 
80 solvents has been noted by Eisen et al.  (4) for 2,4-dinitrophenylsulfonate. 
Also, sodium dodecyl sulfate, an anionic detergent, in 10 per cent aqueous solu- 
tion exhibited the same effect as tween 80 in markedly increasing  the intensity 
of PSI-I-elicited  allergic  reactions  in  PSH-sensitized  guinea  pigs  (25).  How- 
ever, this solvent caused the rapid degradation of PG, presumably to BPO (25). 
Validation of the  Use of Tween 80 Solvents.--The  validity of the use of  tween  80 solvents 
in investigating  the  allergic  cross-reactivities  among  PG and its  degradation  products  rests 
on the observations that tween 80 does not cause an artifactitious  degradation of PG,  and 
that it does not destroy the specificity of the allergic response. 1140  ~'ORMATION OF PENICILLIN" AN"TIGEBT 
A 0.1 M solution of KPG dissolved in a  10 per cent tween 80 aqueous solution was found to 
develop an ultraviolet absorption peak at Xmx 322 In# (due to formation of BPE) at a  much 
flower rate than did a 0.1 zt solution of KPG in water alone. Mter standing at 25°C. for 24 
hours, 0.050 ml. of the KPG aqueous tween 80 solution (5.0 micromols of KPG) was analyzed 
for PSH by paper chromatography. No evidence of PSH was found by the method described 
above, which is capable of detecting 0.5 molar per cent PSH in KPG. Thus, tween 80 did not 
increase the rate of formation of BPE from PG, nor did it cause the formation of PSH from PG. 
TABLE IV 
The Specificity of the Delayed Contact Allergic Reaction Using Tween 80 Solvenls  for Sensitization 
and  glicitation;  Allergic  Cross-Reaction to  D-Penidllamine* 
Sensitized to D-penicillamine 
Elicitor:~ 
1  2 
D-Penicillamine  .......................  ~  ~ 
~Peulcillamine ....................... 
D-Cysteine ..........................  0  0 
L-eysteine ..........................  0  0 
N-Acetyl D-penicillamine  .............  0  0 
D-Benzylpenillamine .................  0  0 
D-Penicillamine disulfide ..............  0  0 
Guinea pig No. 
3  4  s  6 
----]-- 
2+  3+  3+ 
0  1+ 
0  ± 
0  0 
0  0 
0  0 
0  0  0 
2+ 
0 
0 
0 
* See text for methods of sensitization and elicitation. The five or seven tests plus a sol- 
vent control were done simultaneously. 
:~ The elicitors were at 0.1 ~x concentration in ethanol; methyl cellosolve; tween 80 solution 
except for penicillamine disulfide which was at 0.085 concentration in water-tween 80 solu- 
tion  (90:10by  volume).  Solvent controls were 0.  The  elicitor solutions were not primary 
irritants. 
D and ~Penicillamine -- HS-C (CH3) 2 -- *CH(COOH) NH2 
D and L-Cysteine -- HS-CH2-*CH(COOI-I)NH~ 
N-Acetyl D-penicillamine-HS-C(CH3)~ -  CH(COOH) NH-CO-CI-Ia 
D-Penicillamine disulfide -- NH2(COOH)CH-C(CHs)2-S-SC(CHa)2 -  CH(COOH)NH2 
D-Benzylpenillamine -- Text-fig. 1, compound X 
Specificit~ of the Allergic Response to Elicitor in Tween 80 Solvent.--PSH-sensi- 
fized guinea pigs were tested with thiol compounds with varying structural  dif- 
ferences from PSH  (Table  IV).  The  allergenic capacity  of PSH  probably  de- 
pends on its ability to undergo a  thiol-disulfide exchange reaction with cystine 
disulfide linkages of epidermal proteins to form D-penicillamine-cysteine mixed 
disulfide (PSSCy) residues (14, 26). Since low molecular weight thiol compounds 
are  potent  sensitizers  (26),  and  thiol-disulfide  exchange  reactions  have  been 
demonstrated  to  occur in numerous  instances  (14,  26-28),  it is probable  that 
the  other  thiol compounds  tested  can  also  introduce  mixed disulfide  residues 
into  epidermal  proteins.  As  is  clear  from  Table  IV,  PSH-sensitized  animals 
reacted specifically to PSH,  gave occasional faint cross-reactions  to D-cysteine B. B. LEVINE  1141 
and to L-peniciUamine  (L-PSH), and did not cross-react to L-cysteine, N-acetyl- 
D-penicillamine, D-benzylpenillamine,  or  D-penicillamine disulfide.  The  faint 
cross-reactions  to L-PSH may bc due to racemization of L-PSH in v/vo. Com- 
pounds such as penicillamine do undergo racemization readily (29). The forma- 
tion of as little as 1 per cent D-PSH by racemization  of L-PSH could account 
for these faint cross-reactions (cf. Table V). 
Allergenic Equivalence.--The  concept of allergenic equivalence is introduced 
to help determine the chemical pathways which are involved in the formation 
of the penicilliP antigen by irreversible reaction of PG with epidermal proteins. 
By allergenic equivalence is meant the following: If two compounds, A and B, 
both introduce the same antigenic determinant groups into epidermal proteins, 
then if one group of guinea pigs is sensitized (by contact) with A, and another 
group is sensitized with B, the two groups will react indistinguishably when 
tested simultaneously with A and B. That is, the ratio of the intensities  of the 
delayed contact allergic reactions  to A and B will be the same for both groups, 
despite possible differences between the compounds in intraepidermal penetra- 
tion or in chemical reactivity. When this pattern of allergic cross-reactivity  is 
observed,  the two compounds  are said to be allergenically equivalent. If two 
compounds are allergenically equivalent, they can be considered  to introduce 
the same antigenic determinant groups  into epidermal proteins.  If two com- 
pounds cross-react,  but are not allergenically  equivalent,  the compounds may 
introduce non-identical  but structurally similar  determinant groups  into epi- 
dermal proteins,  or one of these compounds must introduce into epidermal pro- 
teins at least one more antigenic determinant group than the other. It must be 
noted that since the method of grading intensity of contact allergic reactions 
is relatively gross, the assessment of allergenic equivalence is subject to some 
experimental error. Thus, if PG and one of its degradation products (compound 
X) are allergenicaUy equivalent, they must both form the same determinant 
groups by reaction with epidermal proteins.  There are three possible chemical 
mechanisms which may account for this: (a) Both PG and X may react with 
proteins to form identical determinant groups.  (b)  Both PG and X  may be 
further degraded in dvo to form a common proantigen,  x (c) PG itself may be 
only negligibly reactive with proteins, but may degrade to X in v/vo. Compound 
X  and/or a  further degradation product of X  may be the proantigen(s)  re- 
sponsible for the formation of the penicillin antigen. These alternative mecha- 
nisms are considered in the Discussion. 
Allergic  Cross-Reactivity  between Penicillin  G  (PG)  and  D-Penicillamine 
(PS//).--PSH was found to elicit allergic reactions in twelve of twenty guinea 
pigs, sensitized with PG. These reactions were usually weaker than were those 
with PG. Also, thirteen of twenty PSH-sensitized  animals gave weaker cross- 
reactions to PG.  Table V  shows that PG and PSH  were not allergenieally 
equivalent.  PG-sensitized  animals  (group  I)  reacted  more  strongly to  PG, 
whereas PSH-sensitized  animals (group VI) reacted more strongly to PSH. ,.-.Z 
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Allergic Cross-Reactivity between PG and 19-Benzylpenicillenic Acid (  BPE).-- 
BPE was found to elicit strong allergic reactions in all six PC--sensitized guinea 
pigs  and  conversely all  six  BPE-sensitized  animals  reacted  strongly  to  PG. 
Table V  shows that  BPE  and  PG were allergenically  equivalent.  Both  PG- 
sensitized  animals  (group  II)  and  BPE-sensitized  animals  (group  III)  gave 
equally intense, or slightly stronger reactions to BPE (Fig. 1). 
TABLE  VI 
Ddayed Contact Allergic Reactivity of Various Degradation Products of Penicillin 
G in Penicillin G and 3-Penicillamine  Sensitized  Guinea Pigs* 
Elicited with:~  Sensitized  witht 
Penicillin  G  D-Penicillamine  Compound§ 
Potassium penicillin  G 
v-Penicillamine 
v-Benzylpenillic acid 
v-Benzylpenillamine 
B  enzylpenilloa]dehyde 
Benzylpenilloaldeby  de 
2-Benzyl-4-sodium  hydroxy- 
methylene-  (5)-oxazolone 
2-Benzyl-4-sodium hydroxy- 
methylene-  (5)-oxazolone 
Monosodium  v~-benzyl- 
penicilloate 
Concen- 
tration 
mols/liteJ 
0.1 
0.1 
0.1 
0.1 
0.1 
0.5 
0.1 
0.5 
0.1 
2+  2+  2+  2+  l+ 
1+  1+  1+  -4-  0 
-4-  .4-  -.v  0  0 
.4-  0  0  0  0 
0  0  0  0  0  0  0 
0  0  0  0  0  0  0 
0  0  0  0  0  0 
0  0  0  0  0  0 
2+  2+  I+  2+ 
1+  0  2+  2+ 
l+  1+  o  2+  o 
1+  .4-  -4-  0  ± 
2+  2+  1+  3+  2+ 
0  0  0  0  0 
0  0  0  0  0 
1+  2+  0  l+  1+  2+  2+ 
* This table represents a composite  of four separate experiments.  In the vertical groups, the reaction  to the 
degradation product is compared with the reactions to penicillin  G and to v-penlcillamine; these three or four 
tests and a solvent control were done simultaneously on an individual animal. 
See text for methods of sensitization  and elicitation. 
§ The test compounds were dissolved  in ethanol-rnethylcellosolve-tween  80 (ECT)  solvent. D-Benzylpenillic 
acid required 0.9 ml. ECT +  0.1 ml. of 1 N NaOH to effect solution,  and monosodium  v-cz-benzylpenicilloate 
was dissolved  in water-methylcellosolve-tween  80 solvent. Solvent control reactions were 0. The test solutions 
were not primary irritants. 
Allergic Cross-Reactivity between PSH and BPE.--As seen  in  Table V  and 
Fig.  1,  PSH and  BPE cross-reacted in six of ten animals,  but the  two com- 
pounds were not allergenically equivalent.  BPE-sensitized animals  (group IV) 
reacted more strongly to BPE, and PSH-sensitized animals  (group V) reacted 
more strongly to PSH. 
Allergic Reactivity of D-Benzylpenicilloic Acid  (BPO).--BPO elicited  weak 
allergic reactions in PG-sensitized guinea pigs and relatively stronger reactions 
in PSH-sensitized animals  (Table VI).  BPO and  PSH were not  allergenically 
equivalent  (Table  VII),  nor  were  BPO  and  PG  allergenically  equivalent 
(Tables VI and VII).  Benzylpenilloaldehyde,  another  degradation  product of 
BPO, gave  consistently  negative  reactions  in BPO-sensitized  animals  (Table 
VII). 1144  FORMATION OF PENICILLIN ANTIGEN 
TABLE VII 
Delayed Contact Allergic Reactivity of D-Benzylpenicilloic Acid, D-Penicillamine, Penicillin G, 
and  Benzylpenilloaldehyde in  Guinea Pigs  Sensitized with  ~-Penicillamine and  D-Benzyl- 
penicilloic Acid; Allergenic lnequivalence between D-Benzylpeniciiloic Acid and  ~-Penlcilla. 
mine* 
Elicited with~  Sensitized with~ 
D-Penicillamine  Compound§ 
Monosodium  o-a-benzylpenicilloat~ 
v-PeniciUamine 
Potassium penieiUin  G 
B  enzylpenilloaldehyde 
Benzylpenilloaldehyde 
Concen- 
tration 
mols/llter 
0.t 
0.1 
0.1 
0.1 
0.5 
Monosodium D-a~-benzyl- 
penicilloate 
2+  l+  t+  i+  l+  l+ 
2-1-  1+  1+  1-4-  1+  -4- 
l+  1+  1+  :h  0  1+ 
0  0  :t:  0  0  0 
0  0  0  0  0  0 
l+  1+  0  2+  i+  1+ 
2+  2+  2+  3+  2+  2+ 
0  0  0  0  0  0 
0  0  0  0  0  0 
* Each vertical column represents a single guinea pig tested simultaneously with the four or five test  com- 
pounds and two solvent controls. 
See text for methods of sensitization and elicitation. 
§ The text compounds were dissolved in ethunol-methylceUosolve-tween  80 solvent except  for monsodium 
n-a-benzylpenleinoate which was dissolved in water-methylcellosolve-tween 80. Solvent reactions were 0. The 
elicitor solutions were non-irritant. 
TABLE VIII 
Ddayed Allergic Contact Reactivity of Penicillin G in Guinea Pigs Sensitized with Benzylpenillo- 
aldehyde and  with 2-Benzyl-4-Sodium tIydroxymethylene-(5)-Oxazolone (BSO);  Allergic 
Cross-Reactions between Benzylpenilloaldehyde and BSO* 
Elicited with~  Sensitized with~ 
Compound§  B enzylpenilloaldehyde  BSO 
Benzylpenilloaldehyde 
BSO 
Potassium penicillin G 
Potassium penicillin G 
Concentra- 
tion 
mols/liter 
0.1 
0.1 
0.1 
0.5 
2+  2+  2+  2+ 
1+  2+  1+  1+ 
0  0  0  0 
0  0  0  O' 
3+  ± 
l+  l+ 
0  0 
0  0 
0  0  0  1-{- 
1-4-  1-4-  1+  2+ 
0  0  0  0 
0  0  0  0 
* Each vertical column represents an individual guinea pig elicited simultaneously with 
the four  test  solutions and  a  solvent control. 
~; See text for methods of sensitization and  elicitation. 
§ The  compounds  were  dissolved  in  ethanol-methylcellosolve-tween 80  (ECT)  solvent 
except for 0.5 ~ potassium penicillin G, which required 0.9 ml. ECT -4- 0.1 ml. H~O to effect 
solution. Solvent control reactions were 0. The test solutions were not primary irritants. 
Allergic  Reactivity  of  D-Benzylpenillic  Add  and  J)-BenzylpeniUamir~.--D- 
Benzylpenillic  acid  gave  occasional  faint  reactions  in  PG-sensitized  animals 
and negative reactions in PSH-sensitized animals  (Table VI). D-Benzylpenilla- 
mine gave negative reactions in both groups (Table VI). 
Allergic Reactiv4ty of BenzylpeniUoaldehyde  and 2-Benzyl-4-Sodium  Hydroxy- B. B. L~.V~E  1145 
metkylene-(5)-Oxazalone (BSO).--Both compounds gave consistently negative 
reactions in PG-sensitized animals (Table VI), and conversely, PG gave nega- 
tive  reactions  in  both  BSO-  and  benzylpenilloaldehyde-sensitized  animals 
(Table VIII). Benzylpenilloaldehyde and BSO cross-reacted with each other 
(Table VIII). 
Allergic Reactivity of Penicillin 0 in PC,- and PSH-Sensitized Guinea Pigs.-- 
Penicillin  O  elicited allergic  cross-reactions  in  both PG-  and PSH-sensitized 
animals (Table IX). Two PG-sensitized animals which cross-reacted to penicil- 
lin O, gave negative reactions to PSH (Table IX). 
TABLE IX 
Ddayed Contact Allergic Reactivity of Sodium Penicillin 0  (NaPO) in Guinea Pigs Sensitized 
with Potassium Penicillin G (KPG) and with D-Penicillamine (PSH) 
Elicited with~  Sensitized  With* 
Compound Concentration  KPG  PSH 
mols/llter 
KPG  0.1  2+  2+  3+  2+  2+  3+  1+  2+  2+  -4-  4-  2+ 
NaPO  0.1  2+  2+  2+  1+  2+  2+  1+  2+  1+  -4-  :t:  2+ 
PSH  0.1  2+  2+  I+  0  1+  0  2+  2+  3+  1+  2+  3+ 
* See text for methods of sensitization and elicitation. Each vertical column represents 
an individual guinea pig in which the three tests and a  solvent control were done simul- 
taneously. 
The elicitors were dissolved in ethanol-methylcellosolve-tween  80 solvents. Solvent con- 
trols were 0. The test solutions were not primary irritants. 
Summary of the Allergic Reactivity of the Degradation Products of PG.- Text- 
fig. 1 summarizes the allergic reactivity of the degradation products of PG. In 
parentheses, following the name of the compound, is placed the average inten- 
sity of the allergic reaction given by a  0.1 ~t ECT solution of the compound 
(BPO is dissolved in WCT) in a PG-sensitized guinea pig reacting 2+  to 0.1 
u  PG in ECT solution. 
DISCUSSION 
The foregoing  experimental results  describe  the allergic  cross-reactivities, 
which exist  among penicillin  G  (PG)  and  its  degradation products,  using 
guinea pig allergic  contact dermatitis as the test system. PG and D-benzyl- 
perdcillenic acid (BPE) were found to be allergenically equivalent (Table V) 
(Fig.  1)  (see  Experimental section for definition of allergenic  equivalence). 
One possible explanation for the observed allergenic equivalence between PG 
and BPE is  that both PG and BPE may react irreversibly with epidermal 
proteins to form the same antigenic determinant groups. However, PG has not 
been demonstrated to react irreversibly with proteins, or with "protein model" 1146  FORMATION OF PENICILLIN  ANTIGEN 
compounds such  as alanine,  cystine, or N-acetyl cysteine in neutral aqueous 
solution (9,  10). Although PG does react with  #-aminothiols such as cysteine 
(9,  10), N-terminal cysteine has  not  been found  to  occur  in  many  proteins 
examined (30-33). 
Another possible explanation for the allergenic equivalence between PG and BPE is 
that PG may rearrange in vivo to BPE which then reacts irreversibly with proteins 
to form the penicillin antigen. There is considerable evidence in support of this view: 
Firstly, BPE is a  highly reactive compound. In pH 7.5 phosphate buffer solution at 
25 °, BPE reacts rapidly with the NH, group of ~-alanine to yield a mixture of diastere- 
omers of #-alanyl-o~-amide of BPO I°a  (13)  Under  these  conditions BPE  appears  to 
react rapidly with the disulfide linkage of oxidized glutathione to yield BPE-gluta- 
thione mixed disulfide (13). Experiments now in progress (25) indicate that BPE reacts 
also with lysine e-NH2 groups and to a lesser extent with cystine disulfide  linkages  n of 
both human 7-globulin and human plasma albumin at pH 7.5. Based on these reactions 
under physiological conditions in vitro,  it may be anticipated that BPE might react 
with epidermal proteins in viw. Secondly, it appears possible that PG may rearrange 
to BPE at a fairly rapid rate in vivo. In pH 7.5 phosphate buffer solution at 37 °, PG 
is hydrolyzed as a first order reaction at a rate of 1.2 per cent per hour  (17).  The  re- 
action products are mainly a mixture of diastereomers of BPO, but the appearance of a 
small quantity of BPE was detected in the degrading PG solution (12). Under identical 
conditions, BPE is hydrolyzed to yield a mixture of diastereomers of BPO at a rate of 
11 per cent per minute (13). Since BPE  is hydrolyzed 550  times more rapidly than 
PG, the appearance of a small amount of BPE in the degrading PG solution indicates 
that PG is hydrolyzed at least partially through the intermediate BPE. In human and 
rabbit serum solution at pH 7.5 and 37  °, PG degrades at a rate of 10 per cent per hour 
(34), presumably to BPO. This marked increase in the rate of degradation of PG ef- 
fected by serum may be due to an increase in the rate of rearrangement of PG to BPE. 
Eagle  (34)  has demonstrated  that  the  responsible serum factors are thermostable. 
Since trace quantities of metal ions such  as Fe  ++ and  Cu  ++ markedly increase the 
rate of hydrolysis of PG to BPO in aqueous solution in vitro (18 e, 19 k), it is possible 
that traces of such metal ions present in serum may be responsible for the rapid degra- 
dation of PG in serum solution. Chain (18 e) has suggested that the effect of these 
metal ions is on the sulfur atom leading to the rupture of the thiazolidine ring and the 
formation of an unstable intermediate, which we believe to be BPE,  that is rapidly 
hydrolyzed to BPO. Thus, it is possible that PG may rearrange to BPE at a  rate in 
the order of 10 per cent per hour in vivo. 
The data presented above suggest that PG may react with tissue proteins in 
vivo primarily through  the active intermediate BPE.  These data however,  do 
not exclude the possibility that PG itself may also react with proteins to some 
extent. 
10a/S-alanyl-~-amide of BPO is more correctly termed N-(D-a-benzylpenicilloyl)-fl-alanine. 
Similarly, ~-lysyl-a-amide of BPO is more correctly termed ~-N-(n-a-benzylpenicilloyl) lysine. 
11 The reaction of BPE with disulfide linkages  of these proteins was  carried  out  in  the 
presence of 0.1 ~ sodium decyl sulfate. B. B. LEVINE  1147 
It might be anticipated that if BPE is the proantigen responsible for the in 
vivo  formation  of  the  penicillin  antigen,  then  BPE  should give  strikingly 
stronger allergic reactions than does PG. In Table V it can be seen that BPE 
gave allergic reactions of equal or only slightly greater intensity than did PG 
in both PG-  and BPE-sensitized animals. This observation,  however,  is  not 
inconsistent with the view that PG reacts irreversibly with epidermal proteins 
through  the  reactive  intermediate,  BPE.  BPE  would  probably  react  with 
keratin in the outer, cornified epidermal layer. Thus, the concentration of BPE 
reaching the sites in the basal epidermal layers necessary to elicit the allergic 
reaction  (35)  would be less than the concentration of PG. Furthermore, since 
BPE is hydrolyzed 550 times more rapidly than PG under physiological condi- 
tions in vitro, the concentration of BPE in epidermis would be considerably less 
than that of PG after a short period of time; e.g., 1 hour. In this regard, although 
2,4-dinltrofluorobenzene  reacts  200  times  more  rapidly  with  aniline,  and 
presumably with free amino groups of proteins than does 2,4-dinitrochloro- 
benzene (36), the two compounds give allergic reactions of equal intensity in 
guinea pigs with allergic contact dermatitis to 2,4-dinitrofluorobenzene (37). 
One of four commercial PG preparations assayed for BPE impurity contained 
a  maximum of 0.18  per  cent BPE.  r' The presence  of  this small amount of 
BPE impurity may not be greatly significant if PG rearranges to BPE at a 
fairly rapid rate in vivo. However, the presence of free BPE in commercial PG 
preparations may be responsible, in part, for allergic reactions to PG which 
occur within seconds after its administration (38). 
The allergic cross-reactivity between PSH and both PG and BPE (Table V) 
merits discussion. The allergenic activity of PSH (Table II) is probably due to 
its ability to undergo a  thiol-disulfide exchange reaction with cystine disulfide 
linkages of epidermal proteins  to  form PSSCy residues  (14,  26).  Its  cross- 
reactions with PG and BPE would appear to be due to the ability of both PG 
and BPE to introduce PSSCy residues into epidermal proteins. The alternative 
possibility  that PSH cross-reacts with PG and BPE because of the structural 
similarity between PSSCy residues and either BPE-cysteine residues or e-lysyl- 
a-amide of BPO residues is unlikely (see Text-fig. 2). This statement is based 
on  the  lack  of  contact  allergic  cross-reactivity  to  PSH  exhibited  by  thiol 
compounds with structural similarity to PSH (Table IV). 
PG and BPE appear to introduce PSSCy groups into epidermal proteins by being 
first hydrolyzed to BPO which reacts with cystine disulfide linkages to form PSSCy 
is Three commercial  preparations of potassium penicillin G (Pfizer, lot 72041-34100; Lilly, 
lot 7013-698920; and Bristol, lot E-7941) contained no detectable BPE. One commercial 
preparation of sodium penicillin G (Pfizer, lot 74-495) contained 0.18 per cent BPE. This 
preparation gave a faintly positive nitroprusside test whereas the potassium penicillin G 
preparations were negative. BPE assays were done spectrophotometrically  as described in 
the  Experimental section. 1148  YORMATION  OF  PENICILLIN  ANTIGEN 
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groups. Supporting this view are: (a) BPO does sensitize guinea pigs to PSH (Table 
VII). (b) BPO  ~3 reacts with cystine in pH 7.5 aqueous solution to yield PSSCy (15). 
PSSCy residues may be formed also by pathways other than the one proposed above, 
but as yet there is no clear experimental evidence in support of other pathways.  14 This 
proposed mechanism for the formation of PSSCy residues offers an explanation for 
the lack of allergic cross-reactivity between benzylpenilloaldehyde or BSO  and  PG 
(Tables VI and VIII). With scission of the postulated intermediate, D-benzylpenamal- 
date-cysteine,  13 one tool of benzylpenilloaldehyde  ~  would be liberated free in  tissue 
for every tool of PSSCy already bound in proteins. Only a  small percentage of the 
free benzylpenilloaldehyde would be expected to react with epidermal proteins (35) 
presumably because of the competitive diffusion of benzylpenilloaldehyde out of the 
epidermis and possibly also because of its degradation in epidermis (e.g., by oxidation). 
Lastly, since BPO and PSH were not allergenically  equivalent, BPO must introduce 
at least one antigenic determinant group other than PSSCy into epidermal proteins. 
The other determinant group may be D-benzylpenamaldate-cysteine mixed disulfide 
(see footnotes 13 and 15). 
Based on  the immunological and  chemical considerations presented above, 
the  schema  in Text-fig. 2  is proposed as a  possible  mechanism  whereby  PG 
may react with epidermal proteins in ~ivo to form  the penicillin antigen. It is 
proposed that  PG rearranges  to BPE;  BPE  reacts with  lysine ~-NH~ groups 
and  cystine disulfide linkages of epidermal proteins  to form a  mixture of the 
disastereomers  of  ~-lysyl-a-amide of  BPO,  TM  and  BPE-cysteine residues re- 
18 The reactive form  of BPO is believed to be D-benzylpenamaldic acid (V'I), traces of which 
appear to exist in tautomeric equilibrium with BPO at pH 7.5. In support of this view is: 
Treatment of a D-a-benzylpenicilloate solution at pH 7.5 with mercuric chloride caused  the 
immediate formation of an intense ultraviolet absorption peak at ), 280 m/z. This peak at X 
280 m# has been shown to be due to D-benzylpenamaldic acid (19 a). Also, the mutarotation 
observed for D-vt-benzylpenicilloate in pH 7.5 buffer solution  (12) probably proceeds through 
the reversible formation of n-benzylpenamaldic add which would cause epimerization of two 
of  the  three  asymmetric  carbon  centers of  BPO.  The  BPO-cystine  reaction may  pro- 
ceed through the formation of D-benzylpenamaldic acid-cysteine mixed disulfide which is a 
Schiff base and would accordingly be expected to degrade to PSSCy (Text-fig. 2). Although 
this degradation is instantaneous in acid solution  (18 b, 19 a), it may proceed slowly at pH 
7.5. 
is PSSCy residues may be formed by degradation of BPE-cysteine residues in vivo. Evidence 
against this possibility  is that both BPE-glutathione mixed disulfide and BPE disulfide appear 
to be stable in pH 7.5 buffer solution (13). The degradation of PG in vivo directly to PSH 
has not been dearly demonstrated (see footnote 3). 
15 Actually, seission of D-benzylpenamaldate-cysteine  would liberate benzylpenaldate ion 
(18 b, 19 a). Under acid conditions in vitro, benzylpenaldic  acid is immediately decarboxylated 
to benzylpenilloaldehyde (18 c)  (Text-fig.  1).  This  decarboxylation appears to  occur  also 
in vivo, since BSO and benzylpeniUoaldehyde cross-react with each other (Table VIII). These 
cross-reactions are probably due to the in vivo degradation of BSO to benzylpenilloaldehyde 
which proceeds through the intermediate, benzylpenaldic acid (19 l). Since PG and BSO do 
not cross-react even at 0.5 ~ concentration (Tables VI, VIII), it appears unlikely that benzyl- 
penaldic acid is a significant proantigen responsible for PG allergy. 1150  FORMATION OF PENICILLIN ANTIGEN 
spectively. BPE is also hydrolyzed to BPO; BPO rearranges  to D-benzylpena- 
maldic  acid  which  reacts  with  cystine  disulfide  linkages  to  yield  ~benzyl- 
penamaldate-cysteine  residues.  PSSCy residues  are  considered  to  be formed 
mainly by degradation of D-benzyl-penamaldate-cysteine and possibly also by 
degradation of BPE-cysteine residues. ~4 The antigenic determinants  responsible 
for PG allergic contact dermatitis in the guinea pig would then be: (a) the dis- 
astereomers  of ¢-lysyl-a-amide of BPO, (b)  BPE-cysteine mixed disulfide,  (c) 
D-benzylpenamaldate-cysteine  mixed  disulfide,  and  (d)  PSSCy. It  must  be 
stressed that other possible pathways for the formation of the penicillin anti- 
gen cannot  be  excluded,  e.g.  the direct  reaction of PG with  epidermal  pro- 
teins,  and  that  the  identity  of  the  antigenic  determinant  groups has not 
been directly demonstrated,  but is based on model considerations. 
The  cross-reactions noted  to occur among  penicillins  G  and  O  and  PSH 
(Table IX) indicate that the two penicillins can cross-react  by virture of the 
common  formation  of  the  PSSCy  determinant  group.  Since  two  PG-sensi- 
tized  animals  cross-reacted  to  penicillin  O  but  not to PSH (Table  IX), the 
two penicillins  may  cross-react  also  because of the structural  similarity  be- 
tween  the  benzyl  and  allylmercaptomethyl  homologues  of  the  other  three 
antigenic determinant groups (Text-figs. 1 and 2). 
It may be that a similar chemical pathway is involved in the formation of the 
penicillin antigen responsible for PG allergy of the immediate type in man. In 
numerous instances, low molecular weight compounds which are allergenic for 
the guinea pig are allergenic for man (26, 39). Also, intracutaneous sensitization 
of  animals  with  low molecular  weight  allergens  has  induced  both  delayed 
contact allergy and immediate,  or serum antibody-dependent,  allergy  against 
the same simple antigenic determinant  group (1, 2, 6, 37, 40-42). With regard 
to PG allergy, positive patch tests have been obtained to PSH in two of three 
patients with allergic contact dermatitis  to PG (43),  and also to BPE in  the 
one such patient  tested (25). Also, allergic reactions of the immediate type to 
D,L-penicillamine have been observed in several patients under  treatment  for 
Wilson's disease (44). However, it cannot be stated that the same determinant 
groups responsible for PG allergic contact dermatitis in the guinea pig are also 
responsible  for  PG  allergy  of  the  immediate  type  in  man.  Aside  from  the 
possibility that PG may be degraded differently in man, differences may arise 
from  the  nature  of the  proteins  with which  PG reacts.  Epidermal  proteins 
contain  relatively  large  numbers  of  reactive  cystine  disulfide  linkages  (5). 
Accordingly,  the mixed disulfide residues would be expected to  be important 
determinant  groups in PG allergic contact dermatitis.  Indeed,  at least one of 
the  possible  mixed  disulfide  determinant  groups,  PSSCy,  has  been  dearly 
demonstrated  to be an important  specific  determinant  of PG allergic contact 
dermatitis. Approximately 60 per cent of PG-sensitized guinea pigs, and two of 
three patients with PG contact dermatitis gave positive allergic cross-reactions B. B. LEWN~  1151 
to PSH. Serum albumins and globulins which may be important carrier proteins 
involved in the formation of the PG antigen responsible for the immediate type 
of allergy, are relatively poor in reactive cystine disulfide linkages (45),  and 
contain large numbers of reactive free lysine ~-NH2 groups.  Thus,  the more 
important  determinant  groups  responsible  for  serum  antibody-dependent 
allergy to PG may be the mixture of diastereomers of ~-lysyl-a-amide of BPOY 
Studies are currently in progress (47) to determine the identity of the anti- 
genic determinant groups responsible for PG allergy of the immediate type in 
man. In early experiments, a  soluble protein conjugate prepared by reacting 
BPE with human "/-globulin at pH 7.5, has been successfully employed as an 
antigen to detect antipenicillin antibody in the serum of human beings with 
PG allergy of the immediate type. This conjugated antigen appears to contain 
mainly the e-lysyl-ot-amide of BPO determinant groups. 
The  identification of  the  allergic  determinant groups  responsible  for  the 
immediate type of PG allergy in man may lead to the preparation of soluble 
conjugated protein antigens useful as clinical reagents for the diagnosis of PG 
allergy. Also, low molecular weight haptene inhibitors can be prepared which 
may have  clinical application  in  the  specific  immunological prevention and 
treatment of PG allergy. Finally, since  PG is used widely as a  therapeutic 
agent, and allergic reactions to PG are common, the penicillin system may be 
useful as a  model for the study of more general problems in human allergic 
disease. 
SUMMARY 
Seven highly purified degradation products of penicillin G (PG) were exam- 
ined with regard to their ability to cross-react allergicalIy with PG. Guinea pig 
allergic contact dermatitis was employed as the test system. Three of these 
degradation products,  D-benzylpenicillenic acid  (BPE),  D-penicillamine,  and 
D-a-benzylpenicilloic acid were found to cross-react with PG and also to be 
capable of inducing delayed contact allergy in the guinea pig. BPE and PG 
cross-reacted  with  particularly  intense  reactions,  and  other  immunologic 
experiments indicated that PG and BPE introduce identical allergic determi- 
nant groups into epidermal proteins. 
These experimental results were correlated with the results of previous studies 
concerning the degradation pathways of PG under physiological conditions in 
vitro, and the chemical reactivities of these degradation products. 
Based on these immunologic and chemical data, a schema is proposed which 
suggests the chemical pathways by which PG may react with epidermal proteins 
16 Consistent  with this possibility  are the observations  of Josephson (46), who demonstrated 
that agglutination  of "penicillin-coated" red blood cells by rabbit "antipenicillin"  sera could 
be inhibited by D-benzylpenicilloic  acid. 1152  FORMATION OF  PENICILLIN  ANTIGEN 
in vivo to  form  the  penicillin  antigen.  The  identity  of  the  specific  antigenic 
determinant groups of the penicillin antigen is suggested. 
The relationship  between  PG allergy of the  contact  dermatitis  type in the 
guinea pig and PG allergy of the immediate type in man is discussed. 
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